Drugs / 8H9
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00582608 Background | Oct 2001 → May 2009 | central nervous system cancer, neuroblastoma, sarcoma | Memorial Sloan Kettering Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 8H9 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00582608 ↗ |
| Modality | Monoclonal antibody | “The purpose of this study is to find out whether the monoclonal antibody 8H9 is useful in finding tumors in your body.” NCT00582608 ↗ |